The effect of cerebral spinal fluid replacement on acute myelopathy induced by intrathecal therapy of leukemia.
Zhongyun
Z
Wang
Wei
W
Xu
Li
L
Liu
Zhengnian
Z
Ding
D000208:Acute Disease; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D002490:Central Nervous System / Q000187:drug effects / Q000473:pathology; D002555:Cerebrospinal Fluid / Q000378:metabolism*; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects; D003907:Dexamethasone / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D005440:Fluid Therapy / Q000379:methods; D006801:Humans; D007278:Injections, Spinal; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects; D010264:Paraplegia / Q000139:chemically induced / Q000628:therapy; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D013118:Spinal Cord Diseases / Q000139:chemically induced / Q000628:therapy*; D016896:Treatment Outcome
D003561:Cytarabine; D003907:Dexamethasone; D008727:Methotrexate